Syschem (India) Ltd

₹ 46.6 -0.89%

14 Aug - close price

About

Incorporated in 1993, Syschem (India) Limited manufactures Active Pharmaceuticals Ingredients (APIs) and bulk drugs.

Key Points

Product Profile:^[1]
API/ Intermediates:
a) Amoxycillin Tri Hydrate
b) Ampicillin Tri Hydrate
c) Cloxacillin Sodium
d) Dicloxacillin Sodium
e) Flucloxacillin Sodium (For export only)
f) Cephalexin
g) Cefixime
h) Cefadroxil
i) Distillation of Specialty Solvents –
DMF, Acetonitrile, Ethyl Acetate and THF

Website BSE

Market Cap ₹ 203 Cr.
Current Price ₹ 46.6
High / Low ₹ 56.0 / 35.3
Stock P/E 102
Book Value ₹ 21.0
Dividend Yield 0.00 %
ROCE 1.47 %
ROE 0.62 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company has reduced debt.
Company is almost debt free.
Company is expected to give good quarter
Company's median sales growth is 40.0% of last 10 years

Cons

Though the company is reporting repeated profits, it is not paying out dividend
Company has a low return on equity of 6.02% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Figures in Rs. Crores

	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
	15.10	20.02	29.52	48.91	43.10	37.11	43.74	74.71	87.53	47.52	77.76	118.87	109.32
	13.75	18.08	26.68	46.39	40.65	35.26	42.66	73.09	86.72	47.45	76.56	116.97	106.86
Operating Profit	1.35	1.94	2.84	2.52	2.45	1.85	1.08	1.62	0.81	0.07	1.20	1.90	2.46
OPM %	8.94%	9.69%	9.62%	5.15%	5.68%	4.99%	2.47%	2.17%	0.93%	0.15%	1.54%	1.60%	2.25%
	0.05	0.13	0.01	0.06	0.00	0.00	0.01	0.15	0.01	0.00	0.02	0.02	0.01
Interest	0.01	0.02	0.06	-0.04	0.10	0.03	0.11	0.01	0.00	0.03	0.04	0.00	0.04
Depreciation	0.68	0.71	0.71	0.59	0.68	0.70	0.74	0.67	0.68	0.68	0.68	0.91	0.76
Profit before tax	0.71	1.34	2.08	2.03	1.67	1.12	0.24	1.09	0.14	-0.64	0.50	1.01	1.67
Tax %	0.00%	0.00%	0.00%	80.79%	0.00%	0.00%	0.00%	123.85%	0.00%	0.00%	0.00%	54.46%	0.00%
	0.71	1.34	2.07	0.39	1.68	1.12	0.23	-0.26	0.14	-0.64	0.50	0.46	1.67
EPS in Rs	0.19	0.35	0.52	0.10	0.42	0.28	0.06	-0.07	0.04	-0.16	0.13	0.11	0.38
Raw PDF

Profit & Loss

Figures in Rs. Crores

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	18	11	4	13	67	93	77	68	59	114	199	332	353
	14	14	5	12	63	89	77	73	58	105	192	328	348
Operating Profit	4	-3	-1	0	3	4	-0	-5	1	9	7	4	6
OPM %	22%	-23%	-24%	0%	5%	4%	-0%	-7%	1%	8%	4%	1%	2%
	1	0	0	-0	-0	-0	0	-0	0	0	0	0	0
Interest	3	1	0	0	0	0	0	0	0	0	0	0	0
Depreciation	2	2	2	2	2	2	2	2	3	3	3	3	3
Profit before tax	1	-5	-3	-2	1	2	-2	-7	-2	6	4	1	3
Tax %	21%	-26%	-27%	-30%	43%	50%	-16%	-24%	-22%	27%	33%	54%
	1	-4	-2	-1	0	1	-2	-6	-2	5	3	0	2
EPS in Rs	0.30	-1.94	-1.13	-0.75	0.17	0.32	-0.79	-2.07	-0.59	1.13	0.69	0.11	0.46
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Compounded Sales Growth
10 Years:	40%
5 Years:	34%
3 Years:	78%
TTM:	45%

Compounded Profit Growth
10 Years:	8%
5 Years:	18%
3 Years:	31%
TTM:	62%

Stock Price CAGR
10 Years:	20%
5 Years:	53%
3 Years:	18%
1 Year:	4%

Return on Equity
10 Years:	-2%
5 Years:	1%
3 Years:	6%
Last Year:	1%

Balance Sheet

Figures in Rs. Crores

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	16	16	16	16	16	19	19	22	23	32	40	44
Reserves	-2	-6	-8	-10	-8	-8	-10	-15	-16	-10	17	48
	32	28	27	22	20	16	17	16	2	2	0	0
	9	13	12	16	29	35	36	55	51	69	107	126
Total Liabilities	55	51	47	44	58	62	62	77	60	93	164	217
	36	34	32	30	29	27	28	30	32	31	31	53
CWIP	0	1	1	1	0	0	1	1	0	0	4	0
Investments	0	0	0	0	0	0	0	0	0	0	0	0
	18	16	15	14	28	35	34	46	28	62	129	164
Total Assets	55	51	47	44	58	62	62	77	60	93	164	217

Cash Flows

Figures in Rs. Crores

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	4	1	0	6	0	-2	3	4	1	-8	-26	-10
	-3	0	0	0	0	2	-4	-4	-1	-2	-6	-22
	-1	-2	-1	-7	-0	-0	-0	-0	-0	11	32	34
Net Cash Flow	0	-1	0	-0	0	0	-0	-0	0	1	-0	2

Ratios

Figures in Rs. Crores

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	143	187	272	124	47	21	47	31	21	135	126	99
Inventory Days	280	228	868	182	80	104	110	199	152	61	107	81
Days Payable	183	290	870	424	151	131	175	221	186	158	198	143
Cash Conversion Cycle	240	124	271	-119	-24	-7	-19	9	-14	38	34	36
Working Capital Days	-12	-139	-564	-319	-50	-20	-36	-1	-15	48	54	39
ROCE %	8%	-11%	-8%	-6%	3%	7%	-8%	-29%	-12%	38%	11%	1%

Shareholding Pattern

Numbers in percentages

4 Recently

	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
	52.10%	53.82%	53.82%	53.82%	53.79%	53.89%	53.89%	53.89%	53.17%	53.17%	57.02%	56.71%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.14%	0.25%	0.25%	0.20%	0.20%	0.18%	0.18%
	47.90%	46.18%	46.19%	46.19%	46.21%	45.97%	45.86%	45.87%	46.63%	46.63%	42.79%	43.11%
No. of Shareholders	9,318	9,167	10,181	10,329	12,186	12,571	13,942	13,310	13,305	13,445	13,223	12,906

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Jun 2025
	24.40%	23.56%	23.59%	10.50%	9.54%	16.34%	53.82%	53.89%	57.02%	56.71%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.25%	0.18%	0.18%
	75.60%	76.44%	76.41%	89.50%	90.46%	83.66%	46.19%	45.86%	42.79%	43.11%
No. of Shareholders	8,793	8,288	8,146	7,994	7,903	8,396	10,181	13,942	13,223	12,906

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

Concalls

Aug 2025

Transcript

Notes
PPT
May 2025

Transcript

Notes
PPT
May 2023

Transcript

Notes
PPT
Nov 2022

Transcript

Notes
PPT
Jul 2022

Transcript

Notes
PPT